Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

ClinicalTrials.gov ID: NCT02694978

Public ClinicalTrials.gov record NCT02694978. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 27, 2026, 5:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Multicenter, Double-Blind, Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

Study identification

NCT ID
NCT02694978
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AMAG Pharmaceuticals, Inc.
Industry
Enrollment
2,014 participants

Conditions and interventions

Interventions

  • Ferumoxytol Drug
  • FCM Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2016
Primary completion
Jan 15, 2017
Completion
Jul 16, 2017
Last update posted
Jul 24, 2023

2016 – 2017

United States locations

U.S. sites
100
U.S. states
27
U.S. cities
86
Facility City State ZIP Site status
Clinical Trial Site Huntsville Alabama
Clinical Trial Site Tucson Arizona 85741
Clinical Trial Site Tucson Arizona
Clinical Trial Site Anaheim California
Clinical Trial Site Chula Vista California
Clinical Trial Site Corona California
Clinical Trial Site Encino California
Clinical Trial Site Fountain Valley California
Clinical Trial Site Granada Hills California
Clinical Trial Site La Mesa California
Clinical Trial Site Orange California
Clinical Trial Site Oxnard California
Clinical Trial Site Riverside California
Clinical Trial Site San Diego California
Clinical Trial Site West Hollywood California
Clinical Trial Site Westminster California
Clinical Trial Site Bristol Connecticut
Clinical Trial Site Norwalk Connecticut
Clinical Trial Site Clearwater Florida
Clinical Trial Site Gainesville Florida
Clinical Trial Site Lauderdale Lakes Florida 33313
Clinical Trial Site Lauderdale Lakes Florida
Clinical Trial Site Miami Florida 33135
Clinical Trial Site Miami Florida
Clinical Trial Site Miami Lakes Florida
Clinical Trial Site North Miami Florida
Clinical Trial Site South Miami Florida
Clinical Trial Site West Palm Beach Florida
Clinical Trial Site Winter Haven Florida
Clinical Trial Site Atlanta Georgia
Clinical Trial Site Augusta Georgia
Clinical Trial Site Savannah Georgia
Clinical Trial Site Thomasville Georgia
Clinical Trial Site Elk Grove Village Illinois
Clinical Trial Site Evergreen Park Illinois
Clinical Trial Site Hazel Crest Illinois
Clinical Trial Site Skokie Illinois 60202
Clinical Trial Site Skokie Illinois
Clinical Trial Site Wichita Kansas
Clinical Trial Site Crestview Hills Kentucky
Clinical Trial Site Metairie Louisiana
Clinical Trial Site New Orleans Louisiana
Clinical Trial Site Baltimore Maryland
Clinical Trial Site Bethesda Maryland
AMAG Pharmaceuticals, Inc. Waltham Massachusetts 02451
Clinical Trial Site Bay City Michigan
Clinical Trial Site Flint Michigan
Clinical Trial Site Saginaw Michigan 48706
Clinical Trial Site Saginaw Michigan
Clinical Trial Site Chesterfield Missouri
Clinical Trial Site Kansas City Missouri
Clinical Trial Site Kirksville Missouri
Clinical Trial Site Las Vegas Nevada
Clinical Trial Site East Setauket New York
Clinical Trial Site Flushing New York
Clinical Trial Site New York New York
Clinical Trial Site Rosedale New York
Clinical Trial Site Asheville North Carolina 28801
Clinical Trial Site Asheville North Carolina
Clinical Trial Site Charlotte North Carolina
Clinical Trial Site Greensboro North Carolina
Clinical Trial Site Hickory North Carolina
Clinical Trial Site Jacksonville North Carolina
Clinical Trial Site Morehead City North Carolina
Clinical Trial Site Raleigh North Carolina
Clinical Trial Site Wilmington North Carolina
Clinical Trial Site Winston-Salem North Carolina
Clinical Trial Site Cincinnati Ohio 45224
Clinical Trial Site Cincinnati Ohio
Clinical Trial Site Marion Ohio
Clinical Trial Site Norman Oklahoma
Clinical Trial Site Tulsa Oklahoma 74104
Clinical Trial Site Tulsa Oklahoma
Clinical Trial Site Jenkintown Pennsylvania
Clinical Trial Site Levittown Pennsylvania
Clinical Trial Site Scottdale Pennsylvania
Clinical Trial Site Smithfield Pennsylvania
Clinical Trial Site Upland Pennsylvania
Clinical Trial Site Greenville South Carolina 29615
Clinical Trial Site Greenville South Carolina
Clinical Trial Site Greer South Carolina
Clinical Trial Site Rapid City South Dakota
Clinical Trial Site Germantown Tennessee
Clinical Trial Site Kingsport Tennessee
Clinical Trial Site Memphis Tennessee
Clinical Trial Site Austin Texas
Clinical Trial Site Fort Sam Houston Texas
Clinical Trial Site Houston Texas 77030
Clinical Trial Site Houston Texas 77081
Clinical Trial Site Houston Texas
Clinical Trial Site Longview Texas
Clinical Trial Site San Antonio Texas 78215
Clinical Trial Site San Antonio Texas 78217
Clinical Trial Site San Antonio Texas 78229
Clinical Trial Site San Antonio Texas
Clinical Trial Site Schertz Texas
Clinical Trial Site Orem Utah
Clinical Trial Site Fredericksburg Virginia
Clinical Trial Site Norfolk Virginia
Clinical Trial Site Seattle Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02694978, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 24, 2023 · Synced Jun 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02694978 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →